DoorDash Partners With Albertsons For On-demand Grocery Delivery
DoorDash Inc (NYSE:DASH) has partnered with food retailer Albertsons Companies Inc (NYSE:ACI) to offer on-demand grocery delivery from nearly 2,000 Albertsons banner stores…
Applied UV Shares Spike Higher; Co, FSG Sign Master Distributor Agreement
Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and
Agora Says To Work With HP To ‘Power Real Time Engagement in OMEN Oasis’
Agora, Inc. (NASDAQ:API), a pioneer and leading platform for real-time engagement (RTE) APIs, today announced it is working with HP Inc. to power RTE for OMEN Oasis - a feature
GSK – Vir Biotech’s Sotrovimab Reduces Hospitalization, Risk Of Death In Adult COVID-19 Patients
GlaxoSmithKline plc (NYSE:GSK) and Vir Biotechnology Inc (NASDAQ:VIR) have announced final, confirmatory results from the Phase 3 COMET-ICE evaluating sotrovimab in high-risk adult…
Horizon Acquires Rights to Arrowhead’s RNAi-Based Gout Treatment Candidate
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) and Horizon Therapeutics plc (NASDAQ:HZNP) have entered into a global collaboration and license agreement for ARO-XDH for uncontrolled gout.…
OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China
OPKO Health Inc’s (NASDAQ:OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in patients with stage 3/4…
DoorDash Shares Move Higher; Co Announces Partnership With Albertsons To Launch On-Demand Grocery Delivery
DoorDash and Albertsons Companies Partner to Launch Unprecedented Access to On-Demand Grocery Delivery
SAN FRANCISCO, June 21, 2021 /PRNewswire/ -- DoorDash (NYSE:DASH), the nation's leading
Hennessy Capital Investment Corp V Shares Up 4.7%; Co Earlier Reported In 8K Filing Co Entered Into Into Warrant Agreement Allowing Amazon To Own Up To 20% Of Co’s M&A Partner PlusAI On Fully Diluted Basis
PlusAI, Inc., a wholly-owned subsidiary of Plus (“PlusAI”), entered into a master purchase agreement effective January 27, 2021 and an initial work order effective January 27, 2021 (collectively, the
McKesson Says TRUSELTIQ Available At Biologics By McKesson
https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2021/TRUSELTIQ-FDA-Approved-for-Treatment-of-Cholangiocarcinoma/